British American Tobaccoの空売り状況は、投資家がBritish American Tobaccoの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

British American Tobacco (NYSE:BTI) 株価情報, 空売り情報

British American Tobacco

British American Tobacco  Industries, p.l.c.

AMEX

The second-largest tobacco company by volume, British American Tobacco sold 505 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the us. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 25.5% stake in ITC limited, the largest Indian cigarette company.

British American Tobacco Industries, p.l.c. Common Stock ADR

British American Tobacco PLC

Boatim Inc

As May opens for business, shell-shocked stock market investors are waving goodbye to April with both hands. While the major stock indexes have <a href="https://www.benzinga.com/markets/25/04/45027002/benzinga-bulls-and-bears-netflix-novavax-intel-and-the-market-begins-to-bounce-back">bounced back</a> moderately over the last week, stocks fell 11% at one point and declined 20% since mid-February, primarily due to <a href="https://www.benzinga.com/trading-ideas/25/04/45050322/how-youll-know-the-tariff-troubles-are-over">tariff troubles</a> affecting the global economy.
That's not all. Consumer spending was at a two-year low in the first quarter of 2025, while first-quarter US gross domestic product fell by 0.3%, fueling talk of a recession on the horizon.
Older traders are talking about a &#8220;Templeton Moment&#8221; right now, and likely with good reason. The term stems from legendary trader John Templeton, who famously borrowed $10,000 to buy shares in every company trading on the New York Stock Exchange for under $1 during a market trough in 1939, during the Great Depression. The list included 104 companies, including 34 that were bankrupt. A few years later, Templeton banked huge gains on all but four stocks when he sold.
Today&#8217;s market could be your opportunity for something similar.
"It doesn&#8217;t resemble a &#8216;Templeton Moment,&#8217; but I would be cautious," said Eugenia Mykuliak, founder and executive director at B2PRIME Group, a global financial services provider for institutional investors. "Today&#8217;s market has more nuances, and we're not close to an &#8216;extreme&#8217; pessimism, unlike the 1930s. Even though there are some well-valued stocks out there, that's certainly not an invitation to buy in bulk."
Unlike the 1930's, which saw economic indicators drag across the board, this market has largely fallen victim to one malady.
&#8220;Uncertainty has been generated by the announcement, delay, magnitude, and duration of tariffs," said Karl Farmer, portfolio manager at Rockland Trust Bank. "With over 40% of the S&amp;P 500's revenues coming from outside the US, the tariffs can have some big impacts on inventory management and purchase plans as producers and consumers face higher prices."
Resulting market uncertainty means less confidence in profit consistency and usually lower multiples that investors place on earnings.
"Higher costs likely lead to lower profits if sellers cannot pass on the price increases to their customers, or at a minimum, it leads to lower consumption," Farmer said. "A lower multiple coupled with lower profits means lower market levels. The longer the tariffs remain, the more likely there will be behavior changes by both producers and consumers, as many will seek alternatives if they believe that higher prices are not temporary."
If the delayed reciprocal tariffs are implemented in full and there have been few negotiated breakthroughs, "then we have not seen the bottom," Farmer added.
Here are today&#8217;s buying opportunities and what to look out for.
<h2 class="wp-block-heading">Stocks To Pounce On At Lower Market Levels</h2>
Templeton or no Templeton, when the markets slide significantly, there's always low-hanging fruit available, and the US stock market is no different. Here are a few names that stock market gurus like in a shallower pricing market.
British American Tobacco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>). Sluggish stock markets spell opportunity for stocks that demonstrate good resilience amid uncertainty, especially those that turn to future-oriented technologies, Mykuliak said.
Shopify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NASDAQ">SHOP</a>). Mykuliak also likes stocks that offer investors a double dose of value.
"Shopify could be another good example of a perfect combination of AI and e-commerce, which are two powerful trends today," she said. "If merchants want to adapt to new retail realities, it&#8217;s a top choice for them."
Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>). According to Farmer, defensive sectors such as consumer staples and utilities have held up very well this year. "Presently, we favor some names in other areas that may have been overly punished, but could provide above-average returns for the patient investor," he said.
Nike tops that list. Nike is no quick fix for a 2025 portfolio, but it makes sense in this market.
"A pop could be had here if tariffs end quickly," Farmer said. "Nike did have issues even before tariffs, but it's a reinvigorating brand, and it's repairing relationships. Plus, Nike shares are down 70% from peak to 2017 levels, which provides a decent entry point."
Air Products and Chemicals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>). Air Products is a market leader in industrial gas trading at a big discount to competitor Linde (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NASDAQ">LIN</a>). "Future growth is coming from new projects and clean energy transition," Farmer said. "Additionally, the company has a strong and predictable recurring revenue model with on-site plants and 20-year contracts." Thermo Fisher Scientific (NYSE: TMO) is a market leader in life sciences, diagnostics and instruments.
"The stock is off 30% in the last three months on fears of spending cutbacks from customers who rely on federal funding for research," Farmer notes. "It's trading at less than market multiples for better earnings growth. Meanwhile, clarity on federal funding should mark a bottom."
<h2 class="wp-block-heading">More Than A "Buy the Dip" Scenario</h2>
As uncertainty prevails in the stock market, money managers are taking a more defensive stance with their portfolios, with one eye on historical trends.
"Historically, when volatility spikes—as it did in early April—the equity markets tend to see large gains one year later," said Andrew Constantinides, a financial advisor at Neil Jesani Wealth Management. "In the short term, however, calling the bottom is much harder. Investors should always remember: There can always be more downside in the market—unless it's at zero."
Constantinides said his firm is primarily focused on value and international stocks.
"Both categories have underperformed U.S. growth stocks over the past 10 years," he noted. "But Q1 of 2025 showed the first real signs of a cycle shift back toward value and international leadership. We favor developed markets, such as Europe and Asia. Our current sector focus is energy and financials—companies with low price-to-earnings ratios and high earnings yield. We have almost no exposure to large-cap tech."
<h2 class="wp-block-heading">5 Dark Horse Stocks Most Investors Aren't Following (But Should)</h2>
Every Friday, five overlooked stocks land on our ‘Whisper Index.' Like Coinbase before it surged 245% higher. And the biotech breakthrough Insmed before it jumped 20% in a single month. Beat Wall Street to these next potential winners. Access the Whisper Index <a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0505&amp;utm_campaign=commandcenter">HERE</a>.
Editorial content from our Expert contributors is intended to be information for the general public and not individualized investment advice. Editors/contributors are presenting their individual opinions and strategies, which are neither expressly nor impliedly approved or endorsed by Benzinga.
Photo: Shutterstock

Opinion

Trading Ideas

SHOP

This Market Is The Buying Opportunity Of A Lifetime

British American Tobacco's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) short percent of float has risen 22.95% since its last report. The company recently reported that it has 12.46 million shares sold short, which is 0.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.02 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>British American Tobacco Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745413229_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for British American Tobacco has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing British American Tobacco's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, British American Tobacco's peer group average for short interest as a percentage of float is 2.87%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Is British American Tobacco Gaining or Losing Market Support?

In today's unpredictable market, investors seeking high yields need to balance risk and reward carefully. With rising volatility, inflation concerns, and fluctuating interest rates, a well-diversified portfolio is crucial to sustaining durable income.
For income-focused <a href="https://in.benzinga.com/news/25/04/44709542/investors-just-poured-3m-into-this-whatsapp-job-app-for-hispanic-immigrants-and-its-already-helping-800-find-work">investors</a>, especially those nearing, or in retirement, capital preservation and <a href="https://www.benzinga.com/markets/25/02/43897884/dividend-investor-making-5-000-per-month-with-632-000-reveals-portfolio-it-takes-time-but-its-doable">dividend</a> sustainability are just as important as yield. A mix of low-volatility assets, tax-efficient strategies, and recession-resistant sectors can help counter market turbulence while delivering consistent cash flow.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>
Reddit has witnessed this balance struggle in a post an investor has created. The 50-year-old poster has spent years building a high-yield portfolio in a brokerage account, but now his main goal is reliable monthly income without sacrificing the principal.
The investor is open to various asset classes such as stocks, bonds, real estate investment trusts, closed-end funds, and/or business development companies but wants to avoid yield traps and foreign stocks due to tax complications.
&#8220;I need durable income. [Ford Motor Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/f#NYSE">F</a>)] is a no, it's a yield trap and has been for years. [Schwab U.S. Dividend Equity ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/schd#NYSE">SCHD</a>)] and [Schwab U.S. REIT ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/schh#NYSE">SCHH</a>)] are great funds, but the yield is too low. I own SCHD in my growth portfolio but continue to sell some every year as I convert to income. Also want to diversify away from options. They are great for income but tend to fluctuate as supply/demand does in down markets,&#8221; he said.
His questions to Reddit investors are what high-yield – over 8% – stocks, ETFs, or funds can sustain payouts long-term, whether there are low-risk business development companies or closed-end funds that won't cut dividends in a downturn, and how can he further diversify beyond his current holdings.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
Redditors have offered a mix of ETF recommendations, individual stock picks, and broader portfolio strategies, so let&#8217;s dive into those.
<h2 class="wp-block-heading">Investor Seeks 8% or More High-Yield Holdings For Durable Income – Reddit Suggests Assets</h2>
Focus on High-Quality BDCs and CEFs for Steady Income
Several commenters recommended business development companies and closed-end funds as core holdings for high, sustainable yields.
&#8220;Two closed-end funds that I like a lot are [Eaton Vance Enhanced Equity Income Fund (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eoi#NYSE">EOI</a>)] and [Eaton Vance Enhanced Equity Income Fund II (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eos#NYSE">EOS</a>)]. They have been around since 2005, have mostly favorable tax treatment on their distributions, and have had better total returns than [JPMorgan Equity Premium Income ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jepi#NYSE">JEPI</a>)​] and [JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jepq#NASDAQ">JEPQ</a>)​],&#8221; a commenter suggested.
Without adding anything else, this Redditor shared several assets for the investor to research: &#8220;[Ares Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arcc#NASDAQ">ARCC</a>)], [Blue Owl Capital Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/obdc#NYSE">OBDC</a>)], [Blackstone Secured Lending Fund (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bxsl#NYSE">BXSL</a>)], [Capital Southwest Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cswc#NASDAQ">CSWC</a>)], [Hercules Capital (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/htgc#NYSE">HTGC</a>)], [Barings BDC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbdc#NYSE">BBDC</a>)], [Bain Capital Specialty Finance (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bcsf#NYSE">BCSF</a>)], [Fidus Investment Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fdus#NASDAQ">FDUS</a>)], [Carlyle Secured Lending (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgbd#NASDAQ">CGBD</a>)], [Sixth Street Specialty Lending (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tslx#NYSE">TSLX</a>)].&#8221;
&#8220;On the same boat (53 years old). Started late but trying to catch up with high-yield stocks. My stocks are: [Ares Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arcc#NASDAQ">ARCC</a>)], [Main Street Capital Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/main#NYSE">MAIN</a>)​], OBDC, HTGC, [Realty Income Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/o#NYSE">O</a>)], [VICI Properties (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vici#NYSE">VICI</a>)], [Altria Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mo#NYSE">MO</a>)], and [British American Tobacco (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bti#NYSE">BTI</a>)]. The last two are the best performers so far,&#8221; a Reddit user wrote.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
Consider Covered-Call ETFs for Tax-Efficient Monthly Income
Given the poster&#8217;s preference for tax-efficient income, several commenters highlighted covered-call ETFs as strong options.
&#8220;[Invesco KBW Premium Yield Equity REIT ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kbwy#NASDAQ">KBWY</a>)], [VanEck Mortgage REIT Income ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mort#NYSE">MORT</a>)], [NEOS Nasdaq-100 High Income ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qqqi#NASDAQ">QQQI</a>)], JEPQ, [Goldman Sachs Nasdaq-100 Core Premium Income ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gpiq#NYSE">GPIQ</a>)], [NEOS S&amp;P 500 High Income ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spyi#NYSE">SPYI</a>)], JEPI, [Goldman Sachs S&amp;P 500 Core Premium Income ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gpix#NASDAQ">GPIX</a>)], and [NEOS Russell 2000 High Income ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iwmi#NASDAQ">IWMI</a>)] are a few. They will probably stay lower during the current volatile cycle, but should do well long term I would think,&#8221; a commenter recommended.
A user mentioned a real estate investment trust option, noting that it pays around 9.5% yield and has a 0.50% expense ratio.
&#8220;Aside from the covered call funds like JEPQ, QQQI, [TappAlpha SPY Growth &amp; Daily Income ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tspy#NASDAQ">TSPY</a>)], and the like, there&#8217;s a [real estate investment trust] ETF from Hoya Capital called [Hoya Capital High Dividend Yield ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/riet#NYSE">RIET</a>)] with a 0.50% expense ratio that pays about a 9.5% yield and seems pretty steady.&#8221;
Read Next:
<ul>
<li>Maker of a life-changing asthma device with 12,000+ patients waiting, FDA clearance, and a 67% drop in attacks — now <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">taking final investors at just $1.52 per share.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
Image: Shutterstock

Small Cap

Personal Finance

ARCC

BBDC

BCSF

BXSL

CGBD

CSWC

FDUS

GPIQ

GPIX

HTGC

NEOS ETF Trust NEOS Russell 2000 High Income ETF

IWMI

JEPI

JEPQ

Powershares Kbw Premium Yield Equity Reit Portfolio

KBWY

MAIN

MORT

OBDC

QQQI

RIET

SCHD

SCHH

SPYI

TSLX

TSPY

VICI

50-Year-Old Investor Craves 8%+ Yield, Snubs Ford, Chases Durable Dividends – 'I Am Willing To Consider Anything' For Monthly Income

WIIM

BRBR

CASY

Coca-Cola European Partners plc Ordinary Shares

CCEP

COKE

FIZZ

PSMT

SISI

SMPL

Shares of several consumer staples stocks are trading higher. The sector may be moving up as investors gravitate towards more defensive assets following market-wide volatility and uncertainty.

For many investors, dividend-focused <a href="https://in.benzinga.com/25/03/44565770/30-year-old-with-65k-in-stocks-sparks-debate-focusing-mostly-on-etfs-but-now-betting-on-bonds-small-caps-and-international-plays">stocks</a> and funds provide a way to generate passive income, whether to supplement retirement, cover day-to-day <a href="https://in.benzinga.com/personal-finance/25/02/43768530/should-married-couples-split-expenses-dave-ramsey-says-no-youre-married-not-roommates">expenses</a>, or even finance small luxuries like annual vacations.
While some aim for significant <a href="https://in.benzinga.com/personal-finance/25/03/44518501/20-year-old-university-student-wants-help-with-buying-dividend-stocks-whats-the-best-way-to-start-reddit-weights-in">dividend</a> payouts to replace their salary, others are happy with modest but constant returns that offer a little extra financial freedom.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>
This is the case of a Reddit user who is exploring this approach. With $30,000 to invest, he's seeking long-term dividend stocks that can grow over the next 20 years until retirement. While he already holds dividend-paying stocks like Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Walt Disney&nbsp; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), he wants to expand his portfolio for stability and future income, even if it's just enough to cover yearly vacations.
&#8220;I currently have some stocks that give out dividends (Apple, Disney) but I&#8217;m looking for others. Long-term stability, that my wife and I can use the dividends as another form of income say in 20 years. Even if it&#8217;s just enough to pay for a yearly vacation here or there. Any thoughts on good companies to choose from?&#8221; he asked.
Let&#8217;s break down the Redditors&#8217; advice received in the comment section.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
<h2 class="wp-block-heading">Where to Invest $30,000 to Generate Enough Income to Cover Yearly Vacations? Reddit Answers</h2>
Put the Money in an ETF
Several commenters recommended Schwab U.S. Dividend Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>) as a core holding because of its dividend yield, historical growth, and the low-risk, diversified exposure it offers investors.
&#8220;Go all in SCHD. Low risk, nice 3.5% starting yield and it will just keep growing,&#8221; a commenter said.
Reinforcing the idea that SCHD fits the poster&#8217;s long-term stability and dividend payout need, this Redditor also suggested he goes with SCHD: &#8220;Since you want some growth and decent payout, SCHD is a great option. 3.5% dividends and 11% growth over the last 10 years each year.&#8221;
&#8220;I would stick with S&amp;P 500 ETFs being young. Put it in a self-direct investment retirement account to avoid taxes,&#8221; a comment reads.
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
Consider High-Yield Dividend Stocks and Trusts
Several commenters suggested higher-yield assets that would generate higher payouts for the investor in the long run.
&#8220;If you want higher yield stocks check: [Verizon Communications (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vz#NYSE">VZ</a>)], [AT&amp;T (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/t#NYSE">T</a>)], [Realty Income Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/o#NYSE">O</a>)], [Altria Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mo#NYSE">MO</a>)], [British American Tobacco (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bti#NYSE">BTI</a>)],&#8221; a Redditor recommended.
A commenter mentioned United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) as a great pick since the company seems to start focusing on higher profit margin areas.
&#8220;UPS pays a solid dividend and the share price has been beaten down a lot on the news that they are reducing Amazon deliveries to focus on higher profit margin areas,&#8221; he said.
Suggesting a very detailed portfolio allocation, this Redditor mentioned several ETFs and individual stocks that he considers would help the poster reach his dividend and growth goals.
&#8220;[Vanguard S&amp;P 500 ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/voo#NYSE">VOO</a>)] $5,000, 1.25% dividends. Do [dividend reinvestment plan] SCHD $5,000, 3.5% dividends. Do [dividend reinvestment plan], [JPMorgan Equity Premium Income ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jepi#NYSE">JEPI</a>)], [JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jepq#NASDAQ">JEPQ</a>)​] ($5,000), 8% combined dividends. Do [dividend reinvestment plan] [Old Republic International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ori#NYSE">ORI</a>)] $2,000, 3% dividends. Do [dividend reinvestment plan] [Waste Management (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wm#NYSE">WM</a>)] and [Automatic Data Processing (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adp#NASDAQ">ADP</a>)] ($3,000), 2% average dividend. Do [dividend reinvestment plan] [Pfizer (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>)] and [Johnson &amp; Johnson (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jnj#NYSE">JNJ</a>)] $2,000, 4.75% average dividend. Do [dividend reinvestment plan] [JPMorgan Chase &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jpm#NYSE">JPM</a>)] and [UnitedHealth Group Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unh#NYSE">UNH</a>)] $2,000, 2% average dividends. Do [dividend reinvestment plan] AAPL and [Microsoft (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>)] $2,000. [The Coca-Cola Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ko#NYSE">KO</a>)] and MO $2,000, 5% average dividends. Do [dividend reinvestment plan] JPM or [American Express (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axp#NYSE">AXP</a>)] $2,000. JPM has good potential growth,&#8221; the suggestion says.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

AAPL

MSFT

Man With $30K To Deploy Wants Dividends For Life – 'Even If It's Just Enough To Pay For A Yearly Vacation Here Or There,' Reddit Reacts

British American Tobacco's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) short percent of float has risen 32.61% since its last report. The company recently reported that it has 10.10 million shares sold short, which is 0.61% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.01 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>British American Tobacco Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743523224_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for British American Tobacco has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing British American Tobacco's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, British American Tobacco's peer group average for short interest as a percentage of float is 3.04%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

British American Tobacco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>), recognized as one of the top three tobacco companies globally by both market capitalization and net sales, has further entrenched itself in the cannabis industry, finalizing a strategic investment of C$124.6 million (approximately $86.8 million) in Organigram Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>), a leading Canadian licensed cannabis producer. The completion of this three-tranche investment cements BAT's role as a major stakeholder in Organigram and highlights the increasing convergence of the tobacco and cannabis sectors.
<h3 class="wp-block-heading">A Strategic Move Amid Market Challenges</h3>
The investment, executed through BAT's wholly owned subsidiary BT DE Investments Inc., marks another significant foray by a major tobacco company into the cannabis industry. As traditional tobacco markets shrink due to declining smoking rates and regulatory pressures, companies like BAT, Philip Morris International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) and Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) are seeking diversification in alternative markets, with cannabis proving an attractive prospect.
According to Paolo De Luca, chief strategy officer at Organigram, "Opportunities in the space have only improved with cannabis valuations at historically weaker levels and many cannabis and hemp companies unable to access cost-efficient growth capital despite fundamentally strong businesses."
Read also: <a href="https://www.benzinga.com/general/health-care/25/02/43666635/zyn-changed-nicotine-forever-are-cannabis-pouches-the-next-big-thing">Zyn Changed Nicotine Forever &#8211; Are Cannabis Pouches The Next Big Thing?</a>
The injection of funds into Organigram is expected to accelerate the company's international expansion and product innovation efforts. The financing will primarily be allocated to a strategic investment pool known as &#8220;Jupiter,&#8221; designed to identify and support growth opportunities in the global cannabis market. Organigram has already deployed portions of this pool, including C$21 million invested in Germany's Sanity Group and C$2.7 million in U.S.-based Open Book Extracts.
<h3 class="wp-block-heading">The Growing Footprint of Big Tobacco in Cannabis</h3>
BAT's move follows a growing pattern of investments by major tobacco firms in the cannabis sector:
<ul>
<li>Altria Group, the parent company of Marlboro, invested $1.8 billion in Canadian cannabis firm Cronos Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) in 2018, acquiring a 45% stake.</li>
<li>Philip Morris International agreed to purchase Israeli medical cannabis inhaler company Syqe Medical in 2023 for up to $650 million.</li>
<li>Imperial Brands invested £75 million ($96.4 million) in Auxly Cannabis Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) and participated in funding Oxford Cannabinoid Technologies, a company focused on cannabis-based pharmaceuticals.</li>
<li>BAT led a $37.6M Series B funding round in Germany's Sanity Group, securing a minority stake in 2022.</li>
</ul>
These moves underscore the increasing alignment between the tobacco and cannabis industries, particularly as regulatory frameworks evolve and consumer preferences shift toward reduced-risk products.
<h3 class="wp-block-heading">Governance And Influence</h3>
As part of the investment agreement, BAT now holds a 30% stake in Organigram's common shares and a 100% stake in its non-voting preferred shares. This arrangement ensures that BAT maintains a level of control without surpassing regulatory thresholds that could trigger anti-competition concerns. Furthermore, BAT has secured the right to nominate up to 30% of Organigram's board of directors, giving it substantial influence over the company&#8217;s strategic direction.
Organigram's preferred shares, initially convertible on a one-to-one basis into common shares, are designed to increase in conversion rate by 7.5% per annum, a mechanism that allows BAT's economic stake in Organigram to grow over time.
<h3 class="wp-block-heading">The Future Of Tobacco-Cannabis Collaborations</h3>
BAT's sustained commitment to cannabis signals that the tobacco industry sees long-term value in cannabis-related products. With global cannabis legalization gaining traction, particularly in Europe and parts of the U.S., these investments position tobacco giants to capture market share in a new, potentially lucrative industry.
As BAT and its competitors continue to navigate regulatory landscapes and consumer demand, the synergy between tobacco expertise and cannabis innovation will likely lead to the development of new product categories, including cannabis-infused vape products and medical formulations. The continued investment in companies like Organigram suggests that big tobacco is not just experimenting with cannabis, it&#8217;s preparing for a future in which cannabis products could rival traditional nicotine offerings.
Read next: <a href="https://www.benzinga.com/markets/cannabis/25/02/43985645/a-tale-of-two-trumps-clemency-for-some-death-for-others-in-his-drug-policy-approach">A Tale Of Two Trumps: Clemency For Some, Death For Others In His Drug Policy Approach</a>
Lead image via Shutterstock

Cannabis

News

Financing

CBWTF

CRON

Big Tobacco's Latest $86.8 Million Cannabis Investment Signals Growing Industry Influence

British American Tobacco's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) short percent of float has risen 22.86% since its last report. The company recently reported that it has 7.19 million shares sold short, which is 0.43% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.24 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>British American Tobacco Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740673835_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for British American Tobacco has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing British American Tobacco's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, British American Tobacco's peer group average for short interest as a percentage of float is 2.69%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on British American Tobacco?

Whales with a lot of money to spend have taken a noticeably bearish stance on British American Tobacco.
Looking at options history for British American Tobacco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish expectations and 75% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $483,225 and 2, calls, for a total amount of $147,365.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $38.0 to $55.0 for British American Tobacco over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for British American Tobacco's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of British American Tobacco's whale activity within a strike price range from $38.0 to $55.0 in the last 30 days. 
<h3>British American Tobacco Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739463348_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BTI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$17.0</td>
<td>$16.8</td>
<td>$16.89</td>
<td>$55.00</td>
<td>$143.6K</td>
<td>273</td>
<td align="right">88</td>
</tr>
<tr>
<td>BTI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$16.6</td>
<td>$16.5</td>
<td>$16.6</td>
<td>$55.00</td>
<td>$121.1K</td>
<td>273</td>
<td align="right">237</td>
</tr>
<tr>
<td>BTI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$1.7</td>
<td>$1.65</td>
<td>$1.7</td>
<td>$40.00</td>
<td>$111.8K</td>
<td>1.0K</td>
<td align="right">668</td>
</tr>
<tr>
<td>BTI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$16.6</td>
<td>$16.4</td>
<td>$16.6</td>
<td>$55.00</td>
<td>$99.5K</td>
<td>273</td>
<td align="right">163</td>
</tr>
<tr>
<td>BTI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$1.4</td>
<td>$1.2</td>
<td>$1.4</td>
<td>$40.00</td>
<td>$59.0K</td>
<td>561</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About British American Tobacco</h3>
The second-largest tobacco company by volume, British American Tobacco sold 555 billion cigarettes in 2023. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the us. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 25.5% stake in ITC limited, the largest Indian cigarette company.
Following our analysis of the options activities associated with British American Tobacco, we pivot to a closer look at the company's own performance.
<h3>Current Position of British American Tobacco</h3>
<ul>
<li>With a volume of 6,016,368, the price of BTI is down -9.48% at $38.69. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 0 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest British American Tobacco options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

What the Options Market Tells Us About British American Tobacco

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.1% on Thursday.
Shares of The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) fell sharply in today's pre-market trading after the company reported <a href="https://in.benzinga.com/news/earnings/25/02/43675459/the-trade-desk-stock-drops-after-q4-revenues-miss-estimates-details">worse-than-expected quarterly revenue results.</a>
Trade Desk reported quarterly earnings of 59 cents per share, which beat the analyst consensus estimate of 56 cents. Quarterly revenue came in at $741.01 million, which missed the analyst consensus estimate of $758.93 million.
Trade Desk shares tumbled 27% to $89.34 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Aspen Aerogels, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) shares fell 30.6% to $8.15 in pre-market trading after the company issued first-quarter guidance below estimates.</li>
<li>Fastly, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) shares tumbled 20.6% to $8.00 in pre-market trading. Fastly reported a fourth-quarter loss of 3 cents per share, down from earnings of 1 cent per share in the prior year&#8217;s quarter. Quarterly revenue came in at $140.58 million, beating the $138.27 million analyst consensus estimate. Fastly expects first-quarter losses of between 9 cents and 5 cents per share, versus the loss of 1 cent estimate, and revenue in a range of $136 million to $140 million, versus the $137.05 million estimate.</li>
<li>Atai Life Sciences N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAI#NASDAQ">ATAI</a>) fell 14.5% to $2.1800 in pre-market trading after the company announced the pricing of public offering of common shares.</li>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) fell 14.1% to $185.94 in pre-market trading after the company reported fourth-quarter results.</li>
<li>Open Lending Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPRO#NASDAQ">LPRO</a>) shares dipped 13% to $5.02 in pre-market trading.</li>
<li>British American Tobacco p.l.c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) fell 9.6% to $38.66 in pre-market trading.</li>
<li>Unilever PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UL#NYSE">UL</a>) declined 6.8% to $55.14 in pre-market trading as the company reported 2024 underlying sales growth of 4.2%.</li>
<li>Pegasystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) fell 6.2% to $99.50 in pre-market trading following fourth-quarter results.</li>
<li>Lionsgate Studios Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) slipped 3.3% to $8.27 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43655479/top-3-utilities-stocks-that-may-collapse-in-q1">Top 3 Utilities Stocks That May Collapse In Q1</a></li>
</ul>

Pre-Market Outlook

Movers

ASPN

ATAI

FSLY

LION

LPRO

PEGA

RDDT

Trade Desk Posts Downbeat Revenue, Joins Aspen Aerogels, Fastly And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

British American Tobacco's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) short percent of float has risen 5.88% since its last report. The company recently reported that it has 5.04 million shares sold short, which is 0.36% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.16 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>British American Tobacco Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739295012_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for British American Tobacco has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing British American Tobacco's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, British American Tobacco's peer group average for short interest as a percentage of float is 2.31%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About British American Tobacco?

As of Jan. 31, 2025, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">British American Tobacco PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>)</h3>
<ul>
<li>On Jan. 27, UBS analyst Faham Baig upgraded British American Tobacco from Neutral to Buy. The company's stock surged around 9% over the past month and has a <a href="https://www.benzinga.com/quote/BTI">52-week high of $39.76</a>.</li>
<li>RSI Value: 75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>BTI Price Action: Shares of British American Tobacco gained 1.1% to close at $39.68 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Estee Lauder Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>)</h3>
<ul>
<li>On Jan. 30, Wells Fargo analyst Christopher Carey maintained Estee Lauder with an Equal-Weight rating and raised the price target from $74 to $80. The company's stock gained around 14% over the past month and <a href="https://www.benzinga.com/quote/EL">has a 52-week high</a> of $62.29.</li>
<li>RSI Value: 77.1</li>
<li>EL Price Action: Shares of Estee Lauder gained 3.9% to close at $85.48 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Turning Point Brands Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>)</h3>
<ul>
<li>On Jan. 10, Roth MKM analyst Scott Fortune reiterated Turning Point Brands with a Buy and maintained a $70 price target. The company's stock gained around 12% over the past five days and has a <a href="https://www.benzinga.com/quote/TPB">52-week high </a>of $66.18.</li>
<li>RSI Value: 73.1</li>
<li>TPB Price Action: Shares of Turning Point Brands gained 5.3% to close at $63.00 on Thursday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43335398/wall-streets-most-accurate-analysts-spotlight-on-3-risk-off-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields</a></li>
</ul>

Top 3 Defensive Stocks That May Implode In Q1

British American Tobacco shares are trading higher after UBS upgraded the stock from Neutral to Buy.

UBS analyst Faham Baig upgrades British American Tobacco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) from Neutral to Buy.

Upgrades

Analyst Ratings

UBS Upgrades British American Tobacco to Buy

XXII

Menthol Cigarette Ban Withdrawn By Trump Administration

<a href="https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-20-zyn-nicotine-pouch-products-after-extensive-scientific-review#:~:text=Today%2C%20the%20U.S.%20Food%20and,following%20an%20extensive%20scientific%20review.">https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-20-zyn-nicotine-pouch-products-after-extensive-scientific-review#:~:text=Today%2C%20the%20U.S.%20Food%20and,following%20an%20extensive%20scientific%20review.</a>
&nbsp;
Today, the U.S. Food and Drug Administration authorized the marketing of 20 ZYN nicotine pouch products through the <a href="https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/premarket-tobacco-product-applications">premarket tobacco product application (PMTA)</a> pathway following an extensive scientific review. This is the first time the agency has authorized products commonly referred to as <a href="https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/premarket-tobacco-product-applications">nicotine pouches</a>, which are small synthetic fiber pouches containing nicotine designed to be placed between a person's gum and lip. &nbsp;
The FDA determined that the specific products receiving marketing authorization met the <a href="https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/premarket-tobacco-product-applications">public health standard</a> legally required by the 2009 Family Smoking Prevention and Tobacco Control Act. This standard considers the risks and benefits of products to the population as a whole.&nbsp;
Among several key considerations, the agency's evaluation showed that, due to substantially lower amounts of harmful constituents than cigarettes and most smokeless tobacco products, such as moist snuff and snus, the authorized products pose lower risk of cancer and other serious health conditions than such products. The applicant also provided evidence from a study showing that a substantial proportion of adults who use cigarette and/or smokeless tobacco products completely switched to the newly authorized nicotine pouch products.

FDA Authorizes Marketing Of 20 ZYN Nicotine Pouch Products after Extensive Scientific Review

<a href="https://www.fda.gov/news-events/press-announcements/fda-proposes-significant-step-toward-reducing-nicotine-minimally-or-nonaddictive-level-cigarettes#:~:text=The%20FDA%20is%20proposing%20to,products%20on%20the%20market%20today" title="https://www.fda.gov/news-events/press-announcements/fda-proposes-significant-step-toward-reducing-nicotine-minimally-or-nonaddictive-level-cigarettes#:~:text=The%20FDA%20is%20proposing%20to,products%20on%20the%20market%20today">https://www.fda.gov/news-events/press-announcements/fda-proposes-significant-step-toward-reducing-nicotine-minimally-or-nonaddictive-level-cigarettes#:~:text=The%20FDA%20is%20proposing%20to,products%20on%20the%20market%20today</a>

Biotech

Government

Regulations

General

'FDA Proposes Significant Step Toward Reducing Nicotine To Minimally Or Nonaddictive Level In Cigarettes And Certain Other Combusted Tobacco Products' - FDA

<a href="https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html" title="https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html">https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html</a>

"F.D.A. Tries Last-Ditch Move to Slash Nicotine Levels in Cigarettes; The agency is asking the White House to move ahead with plans to drastically reduce the addictive substance in traditional tobacco cigarettes." - NY Times

Lilly CEO Says To Test Obesity Drugs For Smoking, Alcohol Abuse

The U.S. Supreme Court heard a challenge against the Food and Drug Administration (FDA) Monday about past bans on flavored liquids for<a href="https://www.benzinga.com/topic/vaping"> e-cigarettes and vapes.</a>
What Happened: Triton Distribution brought a case to the<a href="https://www.benzinga.com/topic/supreme-court"> U.S. Supreme Court</a>, challenging the law that allows the FDA to control the regulation of e-liquids and e-cigarettes.
The FDA previously denied Triton&#8217;s applications to sell flavored e-cigarettes. The concern is that they could appeal to children and teenagers, as reported by <a href="https://www.politico.com/news/2024/12/02/supreme-court-vaping-firm-fda-00192164">Politico</a>.  
Cigarette flavors, except menthol, have been banned by the FDA since 2009.
A final ruling will not be made by the Supreme Court for months. Justices, though, don&#8217;t appear to sympathize with Triton's argument.
"Everybody basically knows that flavors are particularly dangerous in terms of kids starting the use of smoking products," Justice Elena Kagan said.
Triton has the potential to reapply with the FDA. A company attorney said the incoming Donald Trump administration could make things easier, given his past comments on wanting to <a href="https://www.usatoday.com/story/news/politics/2024/12/02/supreme-court-trump-flavored-vapes/76693085007/">save</a> vaping.
Some judges believed the FDA was not consistent on its approval process.
"Their argument is that the guidance were actually a moving target, that either they weren't clear, or you changed the guidance as time went on," Justice Clarence Thomas said.
Read Also: <a href="https://www.benzinga.com/news/24/09/40969670/trump-vows-to-save-vaping-again-despite-past-partial-ban-heres-how-he-plans-to-do-it">Trump Vows To &#8216;Save Vaping Again&#8217; Despite Past Partial Ban. Here&#8217;s How He Plans To Do It</a>
Why It's Important: Under the existing 2009 law, the FDA only approves new tobacco products if they believe they will protect public health. This makes it harder to get new products approved, as the system favors those fighting to get current users of products to stop smoking or prevent new users from starting.
Past appeals courts have approved the FDA's decisions, as reported by <a href="https://www.npr.org/2024/12/02/nx-s1-5205471/fda-vaping-supreme-court">NPR</a>. The conservative Fifth Circuit Court of Appeals rejected the FDA's decision capabilities. It also threatened to allow all vaping products to hit the market, prompting the challenge with the Supreme Court.
With a final ruling likely in June, cigarette and vaping companies could be on the radar of investors.
Cigarette manufacturer Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) owns the NJOY menthol e-cigarette product that has flavored vapes approved by the FDA. Altria was previously an investor in Juul, a leader in the e-cigarette sector. It eventually exchanged its stake for some intellectual property.
Maintaining the FDA's current rules would keep Altria as one of the only companies that can sell approved flavored e-cigarettes. A different decision could see Altria quickly face increased competition.
British American Tobacco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) has watched previous attempts to have some vaping products approved denied by the FDA.
Turning Point Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPI#NYSE">TPI</a>), a past challenger to the FDA's approval process, could benefit if the Supreme Court puts new rules in place.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/10/41516090/social-media-reacts-as-juul-users-get-compensation-through-venmo-after-300m-class-action-settlements">Social Media Reacts As Juul Users Get Compensation Through Venmo After $300M Class-Action Settlements: &#8216;Vaping Actually Paid Off&#8217;</a></li>
</ul>
Image: Shutterstock

Legal

Supreme Court Hears Case Against FDA Ban On Flavored Vapes: Here Are The Stocks To Watch

Ispire Technology

Altria Group

Philip Morris International Inc Common Stock

Philip Morris Intl

RLX Technology Inc. American Depositary Shares, each representing the right to receive one (1) Class A ordinary share

Comments

British American Tobacco

空売り

British American Tobacco (NYSE:BTI) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル